Osteoprotegerin promotes hepatic steatosis through ERK-PPARγ-CD36 pathway

被引：0
|
作者：
Lin, Y. [1 ,2 ]
Li, L. [1 ,2 ]
Yang, G. [3 ]
机构：
[1] Chongqing Med Univ, Key Lab Diagnost Med, Minist Educ, Chongqing, Peoples R China
[2] Chongqing Med Univ, Dept Clin Biochem, Chongqing, Peoples R China
[3] Chongqing Med Univ, Affiliated Hosp 2, Dept Endocrinol, Chongqing, Peoples R China
来源：
DIABETOLOGIA | 2018年 / 61卷
基金：
中国国家自然科学基金;
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
116
引用
收藏
页码：S60 / S60
页数：1
相关论文
共 50 条
  • [1] Osteoprotegerin promotes liver steatosis by targeting the ERK-PPARγ-CD36 pathway
    Li, Kejia
    Luo, Xiaohe
    Yang, Gangyi
    Li, Ling
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2018, 34
  • [2] Osteoprotegerin Promotes Liver Steatosis by Targeting the ERK-PPAR-γ-CD36 Pathway
    Zhang, Cheng
    Luo, Xiaohe
    Chen, Jianrong
    Zhou, Baoyong
    Yang, Mengliu
    Liu, Rui
    Liu, Dongfang
    Gu, Harvest F.
    Zhu, Zhiming
    Zheng, Hongting
    Li, Ling
    Yang, Gangyi
    DIABETES, 2019, 68 (10) : 1902 - 1914
  • [3] Secretory Galectin-3 promotes hepatic steatosis via regulation of the PPARγ/CD36 signaling pathway
    Yu, Huiyuan
    Yang, Fan
    Zhong, Wentao
    Jiang, Xin
    Zhang, Fan
    Ji, Xueying
    Xue, Mengjuan
    Qiu, Yixuan
    Yu, Jiaming
    Hu, Xiaona
    Chen, Jie
    Bao, Zhijun
    CELLULAR SIGNALLING, 2021, 84
  • [4] Diosgenin attenuates nonalcoholic hepatic steatosis through the hepatic FXR-SHP-SREBP1C/PPARα/CD36 pathway
    Chen, Suwen
    Sun, Shangwen
    Feng, Yanan
    Li, Xiu
    Yin, Guoliang
    Liang, Pengpeng
    Yu, Wenfei
    Meng, Decheng
    Zhang, Xin
    Liu, Hongshuai
    Zhang, Fengxia
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2023, 952
  • [5] Prolactin improves hepatic steatosis via CD36 pathway
    Zhang, Pengzi
    Ge, Zhijuan
    Wang, Hongdong
    Feng, Wenhuan
    Sun, Xitai
    Chu, Xuehui
    Jiang, Can
    Wang, Yan
    Zhu, Dalong
    Bi, Yan
    JOURNAL OF HEPATOLOGY, 2018, 68 (06) : 1247 - 1255
  • [6] PEGylated Curcumin Derivative Attenuates Hepatic Steatosis via CREB/PPAR-γ/CD36 Pathway
    Liu, Yu
    Cheng, Fei
    Luo, Yuxuan
    Zhan, Zhu
    Hu, Peng
    Ren, Hong
    Tang, Huadong
    Peng, Mingli
    BIOMED RESEARCH INTERNATIONAL, 2017, 2017
  • [7] Ochratoxin A Induces Steatosis via PPARγ-CD36 Axis
    Zheng, Qian-Wen
    Ding, Xu-Fen
    Cao, Hui-Jun
    Ni, Qian-Zhi
    Zhu, Bing
    Ma, Ning
    Zhang, Feng-Kun
    Wang, Yi-Kang
    Xu, Sheng
    Chen, Tian-Wei
    Xia, Ji
    Qiu, Xiao-Song
    Yu, Dian-Zhen
    Xie, Dong
    Li, Jing-Jing
    TOXINS, 2021, 13 (11)
  • [8] Erucic acid promotes intramuscular fat deposition through the PPARγ-FABP4/CD36 pathway
    Yu, Hengwei
    Guo, Juntao
    Li, Bingzhi
    Ma, Jing
    Abebe, Belete Kuraz
    Mei, Chugang
    Raza, Sayed Haidar Abbas
    Cheng, Gong
    Zan, Linsen
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2025, 298
  • [9] Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARγ in promoting steatosis
    Zhou, Jie
    Febbraio, Maria
    Wada, Taira
    Zhai, Yonggong
    Kuruba, Ramalinga
    He, Jinhan
    Lee, Jung Hoon
    Khadem, Shaheen
    Ren, Songrong
    Li, Song
    Silverstein, Roy L.
    Xie, Wen
    GASTROENTEROLOGY, 2008, 134 (02) : 556 - 567
  • [10] Hyperhomocysteinemia Activates the Aryl Hydrocarbon Receptor/CD36 Pathway to Promote Hepatic Steatosis in Mice
    Yao, Liu
    Wang, Chunjiong
    Zhang, Xu
    Peng, Liyuan
    Liu, Wenli
    Zhang, Xuejiao
    Liu, Yajin
    He, Jinlong
    Jiang, Changtao
    Ai, Ding
    Zhu, Yi
    HEPATOLOGY, 2016, 64 (01) : 92 - 105
12345